948 Results

People

  1. Kris
    Kris
  2. Kelsen
    Kelsen
  3. Motzer
    Motzer
  4. O'Reilly
    O'Reilly
  5. Saltz
    Saltz
  6. Tyson
    Tyson
  7. Gralla
    Gralla
  8. Hudis
    Hudis
  9. Scher
    Scher
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)
  7. Center for Hematologic Malignancies (109)
  8. Genitourinary Oncology Service (106)
  9. Nursing (101)
  10. Surgery (97)
  1. "vomiting"
Formats
  1. Journal Article (896)
  2. Review (27)
  3. Conference Paper (8)
  4. Editorial (6)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Book Section (1)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)

More Groups

People
  1. Mark Kris (70)
  2. David Kelsen (40)
  3. Robert Motzer (39)
  4. Eileen O'Reilly (30)
  5. Leonard Saltz (30)
  6. Leslie Tyson (28)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (44)
  4. 2022 (32)
  5. 2021 (15)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Cancer (47)
  3. Clinical Cancer Research (44)
  4. Lancet Oncology (38)
  5. Gynecologic Oncology (31)
  6. Cancer Treatment Reports (26)

More Publications

Publishers
  1. Elsevier Inc. (145)
  2. American Society of Clinical Oncology (92)
  3. Elsevier Science, Inc. (74)
  4. Springer (72)
  5. Oxford University Press (64)
  6. Wiley Blackwell (63)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer
    Journal Article

    Baselga, J.; Manikhas, A.; CorteĢs, J.; Llombart, A.; Roman, L.; Semiglazov, V. F.; Byakhov, M.; Lokanatha, D.; Forenza, S.; Goldfarb, R. H.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Modified GTX as second-line chemotherapy in advanced pancreatic cancer
    Journal Article

    Dbouk, H.; Ajouz, H.; Shamseddine, A.; Mukherji, D.; O'Reilly, E. M.; Haydar, A.; Kelsen, D.; Naghy, M.; Eloubeidi, M.; Geara, F.; more...
    Gastrointestinal Cancer Research (2013)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: Results from an open-label, multicenter phase i/ii study
    Journal Article

    Slovin, S. F.; Higano, C. S.; Hamid, O.; Tejwani, S.; Harzstark, A.; Alumkal, J. J.; Scher, H. I.; Chin, K.; Gagnier, P.; McHenry, M. B.; more...
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer
    Journal Article

    Tolaney Dr, S. M.; Najita, J.; Sperinde, J.; Huang, W.; Chen, W. Y.; Savoie, J.; Fornier, M.; Winer, E. P.; Bunnell, C.; Krop, I. E.
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer
    Journal Article

    Rathkopf, D. E.; Picus, J.; Hussain, A.; Ellard, S.; Chi, K. N.; Nydam, T.; Allen-Freda, E.; Mishra, K. K.; Porro, M. G.; Scher, H. I.; more...
    Cancer Chemotherapy and Pharmacology (2013)

    Fulltext@MSK | Save
  • Systemic treatment options for untreated patients with metastatic clear cell renal cancer
    Journal Article

    Molina, A. M.; Motzer, R. J.; Heng, D. Y.
    Seminars in Oncology (2013)

    Fulltext@MSK | Save
  • Long-term response to sunitinib therapy for metastatic renal cell carcinoma
    Journal Article

    Molina, A. M.; Jia, X.; Feldman, D. R.; Hsieh, J. J.; Ginsberg, M. S.; Velasco, S.; Patil, S.; Motzer, R. J.
    Clinical Genitourinary Cancer (2013)

    Fulltext@MSK | Save
  • Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma
    Journal Article

    Sherman, E. J.; Su, Y. B.; Lyall, A.; Schoder, H.; Fury, M. G.; Ghossein, R. A.; Haque, S.; Lisa, D.; Shaha, A. R.; Tuttle, R. M.; more...
    Thyroid (2013)

    Fulltext@MSK | Save
  • Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab
    Journal Article

    Schwartzberg, L. S.; Tauer, K. W.; Hermann, R. C.; Makari-Judson, G.; Isaacs, C.; Beck, J. T.; Kaklamani, V.; Stepanski, E. J.; Rugo, H. S.; Wang, W.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • A pilot study of anti-CTLA4 antibody ipilimumab in patients with synovial sarcoma
    Journal Article

    Maki, R. G.; Jungbluth, A. A.; Gnjatic, S.; Schwartz, G. K.; D'Adamo, D. R.; Keohan, M. L.; Wagner, M. J.; Scheu, K.; Chiu, R.; Ritter, E.; more...
    Sarcoma (2013)

    Fulltext@MSK | Save